Fundraising FoxKern Capital, LLC — 2024 Investments
3 investments dated 2024 · listed companies and verified rows first · show all
Aidentified provides wealth network intelligence software that searches 300M+ consumer and professional profiles, maps a user's existing connections to identify introduction paths to prospects, and monitors wealth events (such as IPOs, acquisitions, and property transactions) to signal outreach timing.
Data & InfrastructureFintechSales TechConcord, US
Darr Aley(Director)inG. Thomas Aley(Director)Juliana Spofford(Executive Officer)inThomas C. Rauker(Executive Officer, Director)
BoardMatthew Conway(Director)John Kern, Jr.(Director)
PartnerJay Kern· solo GP
GPN Vaccines is a clinical-stage company developing vaccines against bacterial pathogens, including a vaccine to prevent pneumococcal disease.
BiotechHealthtechNew York, US
Timothy Hirst(Executive Officer, Director)James Selkirk(Executive Officer)in
Co-investorsForepont Capital PartnersShearwater CapitalSouthern Angels
IONETIX manufactures radiopharmaceuticals and operates a network of compact superconducting cyclotrons for PET imaging and cancer therapy production.
BiotechDeep TechHardwareHealthtechMedical DevicesLansing, US
Anthony Stagnolia(Executive Officer)inDavid Eve(Executive Officer)inPhun Phieu(Executive Officer)Kevin Cameron(Executive Officer, Director)CARRIE BUSCH(Executive Officer)in
BoardDavid Martin(Director)
PartnerJay Kern· solo GP
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.